# Sutent Adjunctive Treatment of Differentiated Thyroid Cancer

> **NCT00668811** · PHASE2 · COMPLETED · sponsor: **Medstar Health Research Institute** · enrollment: 23 (actual)

## Conditions studied

- Papillary Thyroid Cancer
- Follicular Thyroid Cancer
- Differentiated Thyroid Cancer

## Interventions

- **DRUG:** SU011248, Sutent

## Key facts

- **NCT ID:** NCT00668811
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668811, "Sutent Adjunctive Treatment of Differentiated Thyroid Cancer". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT00668811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*